Their results indicated that CAV1 (rs7804372) was related to a higher susceptibility to colorectal cancer, with joint effects with smoking status on colorectal cancer susceptibility, and the A allele of CAV1 (rs7804372) polymorphism might act as a potential biomarker for the early diagnosis, prediction, and targets for cancer therapy. This evidence concerns the gene CAV1 and colorectal cancer.